If this file opens in Compatibility Mode using Microsoft Word, convert to the latest document format to avoid potential formatting issues.	

OP RESEARCH PRO00036985 NCT05132504 SCREEING ESNAOLA	

Types:      Research Oncology Treatment
Synonyms:  H50168 , PEMBRO

Cycle 1	Repeat 1 time	Cycle length: 28 days	Day 1	Perform every 1 day x1			Research tolerance: -0/+0 days	Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	History/ Physical exam: The investigator or qualified designee will perform a complete physical exam during the screening period. Medical history will include all active conditions, and any condition diagnosed within the prior 10 years that are considered to be clinically significant by the Investigator.
		  	ONC NURSING COMMUNICATION 5	Interval: --	Occurrences: --	Comments:	ECOG PS
		  	ONC NURSING COMMUNICATION 6	Interval: --	Occurrences: --	Comments:	Staging eval: per RECIST 1.1.
		  	ECG 12-LEAD	Interval: --	Occurrences: --			Imaging
  	CT CHEST W CONTRAST ABDOMEN W CONTRAST PELVIS W CONTRAST	Interval: --	Occurrences: --	Comments:	o Within 28 days prior to the date of registration. 
o IF MRI is desired, please place orders. 
o PET-CT scan can also be used. Please place orders if desired.
			Procedures
  	CASE REQUEST OPERATING ROOM	Interval: --	Occurrences: --	Comments:	Please fill out form for Endoscopic Ultrasound
			Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Within 28 days prior to the date of registration
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Within 28 days prior to the date of registration
			Labs
  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	Within 28 days prior to the date of registration
		  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	Within 28 days prior to the date of registration
		  	CANCER ANTIGEN 19-9	Interval: --	Occurrences: --	Comments:	Within 28 days prior to the date of registration
				Day 25	Perform every 1 day x1			Research tolerance: -0/+0 days	Labs
  	THYROID STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Within 72 hours or the first dose of study intervention
		  	T3, FREE	Interval: --	Occurrences: --	Comments:	Within 72 hours or the first dose of study intervention
		  	T4	Interval: --	Occurrences: --	Comments:	Within 72 hours or the first dose of study intervention
		  	HCG QUALITATIVE, URINE SCREEN	Interval: --	Occurrences: --	Comments:	o For women of child bearing age. 
o To be done within 72 hours or the first dose of study intervention.
		  	PROTHROMBIN TIME WITH INR	Interval: --	Occurrences: --	Comments:	Within 72 hours or the first dose of study intervention
		  	PARTIAL THROMBOPLASTIN TIME (PTT)	Interval: --	Occurrences: --	Comments:	Within 72 hours or the first dose of study intervention
		  	URINALYSIS, AUTOMATED WITH MICROSCOPY	Interval: --	Occurrences: --	Comments:	Within 72 hours or the first dose of study intervention